Globus Medical (NYSE:GMED) Rating Increased to Buy at StockNews.com
Globus Medical (NYSE:GMED – Get Free Report) was upgraded by StockNews.com from a “hold” rating to a “buy” rating in a research report issued on Monday. GMED has been the subject of several other research reports. Wells Fargo & Company cut their price objective on Globus Medical from $95.00 to $93.00 and set an “overweight” […]
